Featured Research

from universities, journals, and other organizations

Antibodies Linked To Kidney Transplant Rejection Identified

Date:
October 2, 2007
Source:
UT Southwestern Medical Center
Summary:
Scientists have identified antibodies associated with transplant rejection of otherwise healthy kidneys. For years, physicians have been perplexed as to why some seemingly well-matched kidneys were still rejected. The new effort has turned up a likely culprit -- antibodies that aren't targeted by current testing methods.

Dr. Peter Stastny, chief of transplant immunology, collaborated with colleagues in Germany in identifying antibodies associated with transplant rejection of otherwise healthy kidneys.
Credit: UT Southwestern Medical Center

UT Southwestern Medical Center researchers, collaborating with colleagues in Germany, have for the first time identified antibodies associated with transplant rejection of otherwise healthy kidneys.

For years, physicians have been perplexed as to why some seemingly well-matched kidneys were still rejected. The collaborative effort has turned up a likely culprit -- antibodies that aren't targeted by current testing methods.

The antibodies in question attack a naturally occurring antigen called MICA, which is found in endothelial cells. The endothelium is the layer of cells lining the inside of the blood vessels. Each person has one or two of the more than 60 varieties of MICA antigens currently known.

"When you put a transplant in, the blood of the new host comes into contact first with the endothelium of the donor organ. That's where the host first meets the donor and where rejection starts," said Dr. Peter Stastny, professor of internal medicine, chief of transplant immunology and an author on the study.

"The bottom line is that the data suggests that failure of otherwise well-matched kidneys may be caused by these antibodies. We are not saying that all such kidneys fail because of antibodies against MICA, but this may be part of it," he said.

Dr. Stastny believes more research will be needed to show whether this is the direct cause, but the results offer critical direction in finding new explanations of why good transplants go bad and discovering potentially new avenues for screening to prevent rejection of transplanted kidneys.

Available kidneys remain in short supply, and more than 73,000 people await kidney transplants in the U.S., making successful transplants critical. Roughly 14,000 transplants were performed during the first half of 2007.

In Texas, about 600 kidney transplants have been performed this year. Between 89 percent and 95 percent of transplanted kidneys continue to function one year after the operation, according to the National Kidney Foundation.

UT Southwestern researchers became interested several years ago in the possibility that there might be some antigens in the kidney that were not present on lymphocytes, which are the cells used for typing and cross-matching for kidney transplants. Lymphocytes are white blood cells that carry out the body's immune response.

"If the antigens are not present on the lymphocytes, then the usual lymphocyte cross-match would not detect such antibodies," Dr. Stastny said.

Researchers first had to confirm that the antigens were present in the kidneys, then follow enough cases to determine whether the antibodies against MICA antigens correlated with rejection of otherwise healthy kidneys. For that, UT Southwestern investigators collaborated with researchers at the University of Heidelberg, which maintains a large depository of data and samples on transplant cases.

"They were able to provide a large number of samples -- 1,910 -- all taken before the transplant, so we were able to analyze them with our MICA antibody assay," Dr. Stastny said. "We found that there was a strong correlation. The presence of the antibodies against MICA was associated with earlier rejection of the kidney grafts.

"It doesn't prove that the antibody causes the rejection, but it suggests it." In addition, researchers discovered that the patients who were considered a good risk in clinical transplantation were the ones who showed the most marked effect of these antibodies against MICA.

The research appeared recently in the New England Journal of Medicine, along with an accompanying editorial.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "Antibodies Linked To Kidney Transplant Rejection Identified." ScienceDaily. ScienceDaily, 2 October 2007. <www.sciencedaily.com/releases/2007/09/070926172239.htm>.
UT Southwestern Medical Center. (2007, October 2). Antibodies Linked To Kidney Transplant Rejection Identified. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/09/070926172239.htm
UT Southwestern Medical Center. "Antibodies Linked To Kidney Transplant Rejection Identified." ScienceDaily. www.sciencedaily.com/releases/2007/09/070926172239.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins